Moderna continues to expand its mRNA platform for a range of additional clinical applications and routes of administration including a modality for lung delivery
AbbVie receives the option to license worldwide rights to CUG252 from Cugene, a clinical-stage and potential best-in-class Treg-selective IL-2 mutein, building on AbbVie's commitment to developing novel therapies in immunology
Researchers have developed a plasma-based disinfectant generated with the help of cold atmospheric pressure plasma (CAP) which could act as a green decontaminant for Covid-19
The Karnataka Health Promotion Trust held a day-long session in New Delhi to address health care challenges
Agreement builds on 15 years of successful collaboration between AbbVie and Richter, including globally launched cariprazine products
Agreement builds on previous Novartis success using emerging technologies to develop first-in-class gene therapies for neurological disorders
Dr Ratna Puri from Sir Ganga Ram Hospital, Delhi is the Chairperson of the expert committee.
Taisho Pharmaceutical will bring its experience and expertise in the research and development of therapeutic products to the collaboration.
Novel delivery of established growth and neurotrophic factors enables local, sustained release for greater efficacy
The aim is to create an awareness programme that will drive diabetic patients to get their eyes tested regularly
Subscribe To Our Newsletter & Stay Updated
